Literature DB >> 10857215

[The Menopause Rating Scale (MRS II): methodological standardization in the German population].

P Potthoff1, L A Heinemann, H P Schneider, H P Rosemeier, G A Hauser.   

Abstract

The Menopause-Rating-Scale (MRS I) was used in clinical practice since 1992. The physician had to document the severity of 10 important estrogen-related climacteric symptoms. Practical experience and a critical methodological evaluation justified a revision: The MRS I should be converted into a self-administrative rating scale, the wording somewhat optimized, the layout adjusted and one item added. The standardization of the new scale (MRS II) was performed in a representative sample of the German population aged 45-60 years. Three dimensions were extracted from the menopausal symptoms using multivariate statistical techniques: somato-vegetative, psychological, and urogenital complexes of symptoms. A simple evaluation scheme was developed for the MRS II by summing up scoring points. Reference values for the frequency of 4 levels of intensity of complaints in the population were defined and provided for purposes of comparison. The MRS II meets a high methodological standard as an instrument standardized in the population. Moreover, it is convenient to apply this instrument in daily practice in order to quantitate variation of menopausal complaints.

Entities:  

Mesh:

Year:  2000        PMID: 10857215

Source DB:  PubMed          Journal:  Zentralbl Gynakol        ISSN: 0044-4197


  20 in total

Review 1.  Chinese herbal medicine for menopausal symptoms.

Authors:  Xiaoshu Zhu; Yuklan Liew; Zhao Lan Liu
Journal:  Cochrane Database Syst Rev       Date:  2016-03-15

2.  Quality of life and hormone use: new validation results of MRS scale.

Authors:  Jürgen Dinger; Thomas Zimmermann; Lothar Aj Heinemann; Diana Stoehr
Journal:  Health Qual Life Outcomes       Date:  2006-05-31       Impact factor: 3.186

3.  The Menopause Rating Scale (MRS) as outcome measure for hormone treatment? A validation study.

Authors:  Lothar A J Heinemann; Thai DoMinh; Frank Strelow; Silvia Gerbsch; Jörg Schnitker; Hermann P G Schneider
Journal:  Health Qual Life Outcomes       Date:  2004-11-22       Impact factor: 3.186

Review 4.  Assessment of the climacteric syndrome: a narrative review.

Authors:  Marina Sourouni; Martina Zangger; Livia Honermann; Dolores Foth; Petra Stute
Journal:  Arch Gynecol Obstet       Date:  2021-07-06       Impact factor: 2.344

5.  Translation, Reliability, and Validity Test of Gujarati Version of Menopause Rating Scale in Postmenopausal Women for Menopause-Related Symptoms.

Authors:  Khushali Ajani; Dhvani Nimavat; Monika Vidja; Anjali Moradiya; Dharti Panchasara; Sonali Bhalodiya; Krupali Miyatra; Krupa Dharmeshkumar Tank
Journal:  Indian J Community Med       Date:  2021-03-01

6.  Correlation between the modified Kupperman Index and the Menopause Rating Scale in Chinese women.

Authors:  Minfang Tao; Hongfang Shao; Changbing Li; Yincheng Teng
Journal:  Patient Prefer Adherence       Date:  2013-03-20       Impact factor: 2.711

7.  International versions of the Menopause Rating Scale (MRS).

Authors:  Lothar A J Heinemann; Peter Potthoff; Hermann P G Schneider
Journal:  Health Qual Life Outcomes       Date:  2003-07-30       Impact factor: 3.186

8.  The Menopause Rating Scale (MRS) scale: a methodological review.

Authors:  Klaas Heinemann; Alexander Ruebig; Peter Potthoff; Hermann P G Schneider; Frank Strelow; Lothar A J Heinemann; Minh Thai Do
Journal:  Health Qual Life Outcomes       Date:  2004-09-02       Impact factor: 3.186

9.  Use acupuncture to relieve perimenopausal syndrome: study protocol of a randomized controlled trial.

Authors:  Ying Li; Hui Zheng; Qianhua Zheng; Ling Zhao; Erqi Qin; Yu Wang; Qian Zeng; Huabin Zheng; Yu Zhao; Wei Sun; Xiaoxia Zhang; Zhishun Liu; Baoyan Liu
Journal:  Trials       Date:  2014-05-30       Impact factor: 2.279

10.  Danggwijagyaksan for climacteric syndrome in peri- and postmenopausal women with a blood-deficiency dominant pattern: study protocol for a randomized, double-blind, placebo-controlled pilot trial.

Authors:  Mikyung Kim; Ae-Ran Kim; Hyo-Ju Park; Ojin Kwon; Joo-Hee Kim; Eun-Ji Park; Seon-Eun Baek; Jeong-Eun Yoo; Jun-Hwan Lee
Journal:  Trials       Date:  2018-01-15       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.